TY - JOUR
T1 - Importance of lipid levels in elderly diabetic individuals - Baseline characteristics and 1-year survey of cardiovascular events
AU - Hayashi, Toshio
AU - Kawashima, Seinosuke
AU - Itoh, Hideki
AU - Yamada, Nobuhiro
AU - Sone, Hirohito
AU - Watanabe, Hiroshi
AU - Hattori, Yoshiyuki
AU - Ohrui, Takashi
AU - Yoshizumi, Masashi
AU - Yokote, Koutaro
AU - Kubota, Kiyoshi
AU - Nomura, Hideki
AU - Umegaki, Hiroyuki
AU - Iguchi, Akihisa
PY - 2008
Y1 - 2008
N2 - Background: The respective incidences of ischemic heart and cerebrovascular disease (IHD, CVD) are high in diabetic individuals. Complications of dyslipidemia increase the risk, but direct evidence is limited, so a cohort prospective study (Japan-CDM) was conducted. Methods and Results: The study group comprised 4,014 subjects with type 2 diabetes (1,936 women, 2,078 men; mean age 67.4±9.5 years) who were divided into dyslipidemic patients (79.1%) with or without medication (medicated, 50.9%; not medicated, 28.2%) and normo-lipidemic patients (20.9%). The incidence of IHD, CVD, arteriosclerosis obliterans (ASO), congestive heart failure (CHF) and death was assessed. IHD and CVD occurred in 0.82 and 0.67%, respectively, during the first year following registration. CHF, ASO and sudden death occurred in 0.27%, 0.12% and 0.12%, respectively. There was a significant statistical difference in the relation of elevated levels of high-density lipoprotein-cholesterol to lower rates of IHD and CVD. IHD and CVD in males were dependent on the level of low-density lipoprotein-cholesterol (LDL-C): 0.45%, 1.56%, 1.78%, 1.91% and 2.34% were observed in less than 2.11, 2.11-2.62, 2.63-3.15, 3.16-3.67, and more than 3.68 mol/L of LDL-C. In the lowest LDL-C group, death other than from vascular diseases was increased. Age, sex (male) and complicated hypertension increased the risk of events. Patients who were prescribed antihyperlipidemic agents suffered less events than patients who were not being treated, which suggests direct effects of therapy. Conclusion: Strict lipid control may be effective for reducing the incidence of vascular events in Japanese diabetic individuals.
AB - Background: The respective incidences of ischemic heart and cerebrovascular disease (IHD, CVD) are high in diabetic individuals. Complications of dyslipidemia increase the risk, but direct evidence is limited, so a cohort prospective study (Japan-CDM) was conducted. Methods and Results: The study group comprised 4,014 subjects with type 2 diabetes (1,936 women, 2,078 men; mean age 67.4±9.5 years) who were divided into dyslipidemic patients (79.1%) with or without medication (medicated, 50.9%; not medicated, 28.2%) and normo-lipidemic patients (20.9%). The incidence of IHD, CVD, arteriosclerosis obliterans (ASO), congestive heart failure (CHF) and death was assessed. IHD and CVD occurred in 0.82 and 0.67%, respectively, during the first year following registration. CHF, ASO and sudden death occurred in 0.27%, 0.12% and 0.12%, respectively. There was a significant statistical difference in the relation of elevated levels of high-density lipoprotein-cholesterol to lower rates of IHD and CVD. IHD and CVD in males were dependent on the level of low-density lipoprotein-cholesterol (LDL-C): 0.45%, 1.56%, 1.78%, 1.91% and 2.34% were observed in less than 2.11, 2.11-2.62, 2.63-3.15, 3.16-3.67, and more than 3.68 mol/L of LDL-C. In the lowest LDL-C group, death other than from vascular diseases was increased. Age, sex (male) and complicated hypertension increased the risk of events. Patients who were prescribed antihyperlipidemic agents suffered less events than patients who were not being treated, which suggests direct effects of therapy. Conclusion: Strict lipid control may be effective for reducing the incidence of vascular events in Japanese diabetic individuals.
KW - Diabetes mellitus
KW - Elderly
KW - HDL-cholesterol
KW - Ischemic heart disease
KW - LDL-cholesterol
UR - http://www.scopus.com/inward/record.url?scp=40949127472&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40949127472&partnerID=8YFLogxK
U2 - 10.1253/circj.72.218
DO - 10.1253/circj.72.218
M3 - Article
C2 - 18219157
AN - SCOPUS:40949127472
VL - 72
SP - 218
EP - 225
JO - Circulation Journal
JF - Circulation Journal
SN - 1346-9843
IS - 2
ER -